George Trainor

George L. Trainor, Ph.D., has 38+ years of experience in the biotechnology and pharmaceutical industries and is currently an industry consultant (Trainor Consulting, LLC).

He has expertise in drug discovery strategy development and execution, medicinal chemistry, and the application of transformative technologies.

Leading teams of more than 100 scientists, he has advanced more than 35 drug candidates into clinical development across a spectrum of therapeutic areas, including antivirals, cancer, neuroscience, and inflammation. His team provided key discovery support that enabled the successful launch of SustivaTM for HIV disease.